NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. PRYMY
3. SPY
4. SKA-B
5. PBA
6. ALAR
7. CCH:LN
8. META
9. CCHGY
10. PRY:IM

Go back to NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
(NASDAQ: NRXP) Delayed: 3.87 +0.01 (0.26%)
Previous Close $3.86    52 Week High $ 
Open $3.91    52 Week Low $ 
Day High $3.99    P/E N/A 
Day Low $3.80    EPS $ 
Volume 668,701